Published in Gene Therapy Weekly, February 13th, 1995
Researchers believe the most effective HIV vaccine is likely to be a live virus, which will prime the body to mount a spirited reaction to HIV. Many, though, worry about giving healthy people even a weakened form of HIV, since it might cause cancer, immune suppression or even AIDS.
So now a team from the U.S. National Institute of Allergy and Infectious Diseases has come up with a novel strategy: a live but weakened HIV virus that can be killed off once it does its job.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly